Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Biopharmaceutics/ABS form advisory team to advance filings for anticancer drug

Feb. 14, 1997

TK inhibitors disclosed by RCT

Feb. 14, 1997

BASF prepares dolastatin derivatives

Feb. 14, 1997

Retinoid series for cancer

Feb. 14, 1997

Idec acquires rights to anticancer agent

Feb. 13, 1997

Basal lamina-based drugs offer promise for tumor metastasis

Feb. 13, 1997

Supplemental NDA filed for Photofrin

Feb. 13, 1997

Orphan Medical expands clinical trials of Busulfanex

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...